They enhance anti-tumor immunity by secreting IFN-γ, IL-2, IL-4 and IL-17, which activate cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and macrophages (62, 63). The gene discussed is IFNG; the disease is neoplasm.